ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Nevro Corp

Nevro Corp (NVRO)

5.79
0.02
(0.35%)
Cerrado 10 Marzo 2:00PM
5.79
0.00
( 0.00% )
Pre Mercado: 6:35AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
5.79
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
882
0.00 Rango del Día 0.00
3.165 Rango de 52 semanas 15.245
Capitalización de Mercado [m]
Precio Anterior
5.79
Precio de Apertura
-
Última hora de negociación
07:35:04
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,053,712
Acciones en circulación
37,471,622
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.35
Beneficio por acción (BPA)
-2.46
turnover
425.17M
Beneficio neto
-92.21M

Acerca de Nevro Corp

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Nevro Corp is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker NVRO. The last closing price for Nevro was US$5.79. Over the last year, Nevro shares have traded in a share price range of US$ 3.165 to US$ 15.245.

Nevro currently has 37,471,622 shares in issue. The market capitalisation of Nevro is US$216.96 million. Nevro has a price to earnings ratio (PE ratio) of -2.35.

NVRO Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.061.047120418855.735.815.7259621255.78011446CS
40.061.047120418855.735.815.7111682065.73311596CS
121.65540.02418379694.1355.813.16510537125.28216687CS
260.9820.37422037424.816.853.1657525395.15821314CS
52-9.43-61.957950065715.2215.2453.1656742626.91693741CS
156-63.13-91.598955310568.9278.93.16559378223.76920418CS
260-110.33-95.0137788495116.12188.143.16554200158.26359567CS

NVRO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Nevro?
El precio actual de las acciones de Nevro es US$ 5.79
¿Cuántas acciones de Nevro están en circulación?
Nevro tiene 37,471,622 acciones en circulación
¿Cuál es la capitalización de mercado de Nevro?
La capitalización de mercado de Nevro es USD 216.96M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Nevro?
Nevro ha negociado en un rango de US$ 3.165 a US$ 15.245 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Nevro?
El ratio precio/beneficio de Nevro es -2.35
¿Cuál es el ratio de efectivo a ventas de Nevro?
El ratio de efectivo a ventas de Nevro es 0.51
¿Cuál es la moneda de reporte de Nevro?
Nevro presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Nevro?
El último ingresos anual de Nevro es USD 425.17M
¿Cuál es el último beneficio anual de Nevro?
El último beneficio anual de Nevro es USD -92.21M
¿Cuál es la dirección registrada de Nevro?
La dirección registrada de Nevro es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Nevro?
La dirección del sitio web de Nevro es www.nevro.com
¿En qué sector industrial opera Nevro?
Nevro opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TBITrueBlue Inc
US$ 7.60
(38.94%)
44
SRIStoneridge Inc
US$ 6.95
(34.69%)
97
VELVelocity Financial Inc
US$ 25.99
(30.15%)
1
GBTGGlobal Business Travel Group Inc
US$ 9.99
(27.91%)
10
ETYEaton Vance Tax Managed Diversified Equity Income Fund
US$ 17.99
(25.45%)
1
BFKBlackRock Municipal Income Trust
US$ 6.01
(-40.26%)
3
NPWRNET Power Inc
US$ 3.08
(-35.16%)
296.74k
ASANAsana Inc
US$ 12.22
(-26.74%)
882.57k
FLOCFlowco Holdings Inc
US$ 17.00
(-22.23%)
430
RDWRedwire Corporation
US$ 9.151
(-18.73%)
94.04k
NIONIO Inc
US$ 4.72
(5.83%)
4.66M
KSSKohls Corporation
US$ 10.15
(-15.77%)
1.86M
BBAIBigBear ai Holdings Inc
US$ 3.10
(-1.27%)
1.77M
UMCUnited Microelectronics Corp
US$ 6.78
(0.00%)
1.44M
TALTal Education Group
US$ 13.16
(1.94%)
1.34M

NVRO Discussion

Ver más
TrendTrade2016 TrendTrade2016 2 meses hace
NVRO STRONG IN A BAD MARKET
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
NVRO STRONG INTO 2025
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
NVRO MONSTER
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
NVRO BIO BEAST TAKING OFF
👍️0
whytestocks whytestocks 5 años hace
News: $NVRO Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro   (NYSE: NVRO) , a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a...

Find out more NVRO - Here's Why Nevro Stock Bounded Higher on Thursday
👍️0
joseytheoutlawwales joseytheoutlawwales 5 años hace
New system with both lower frequency ranges and combination therapies, in addition to HF10 (10k Hz) ranges, and brand new patient peripherals (ie, remote, charger, etc) should be out in November I’m told.

Should be interesting.
👍️0
whytestocks whytestocks 6 años hace
News: $NVRO Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...

In case you are interested https://marketwirenews.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-8248992.html
👍️0
stocktrademan stocktrademan 6 años hace
NVRO buy 61.44



normal chart







log chart






👍️0
KOmani KOmani 7 años hace
Down 14% on no news at all ....

Perhaps a little overdone?
👍️0
jimmybob jimmybob 8 años hace
$NVRO now up 49.3% YTD,closing at another all-time high today,and hitting all-time highs intra-day.. story not over… http://www.optionmillionaires.com/bull-case-nevro-nvro-update/
👍️0
jimmybob jimmybob 9 años hace
The Bull Case on Nevro ( $NVRO ) - Update : http://www.optionmillionaires.com/bull-case-nevro-nvro-update/ $MEDT $STJ $BSX $NURO $ETRM
👍️0
BudFoxWallStreet BudFoxWallStreet 9 años hace
Nevro's Revenue Surges, Lower Than Expected Loss |

https://www.medtechy.com/the-ticker/articles/2016/nevros-revenue-surges-lower-than-expected-loss

👍️0
jimmybob jimmybob 9 años hace
Snapshot on why I have/continue to love $NVRO (CC still going w/ speechless analysts) - http://www.optionmillionaires.com/bull-case-nevro-nvro/

👍️0
jimmybob jimmybob 9 años hace
One of the best growth stories out there, $NVRO revenue up 114% in ’15 looking for 137%+ in ’16

👍️0
jimmybob jimmybob 9 años hace
$NVRO - strong support around $65 , like for new all-time highs before Q1 earnings in May

👍️0
jimmybob jimmybob 9 años hace
Love the breakout on $NVRO friday.. $70+ next

👍️0
BudFoxWallStreet BudFoxWallStreet 9 años hace
Here is Nevro's JP Morgan presentation. They are also presenting at Leerink tomorrow but it is probably the same presentation.

https://www.medtechy.com/boards/companies/nevro/3825

👍️0
jimmybob jimmybob 9 años hace
Key theme from $NVRO @ #JPM16 : ’Expanding Market opportunities’ outside of $1.5 addressable market where its already taking sizable share
👍️0
RealGenius RealGenius 9 años hace
No way 1 billion MC justified here, when not even profitable.
👍️0
quaerere quaerere 10 años hace
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
👍️0
stocktrademan stocktrademan 10 años hace
$NVRO recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com

[img]http://charts.stockscores.com/chart.asp?

TickerSymbol=NVRO&TimeRange=400&Interval=d&Volume=1&ChartType=CandleStick&ChartWidth=830&ChartHeight=500&LogSc

ale=None&Band=BB&avgType1=EMA&movAvg1=50&indicator1=MACD&candles=redgreen[/img]

big daily chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

big weekly chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVRO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVRO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVRO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/news - http://finance.yahoo.com/q/h?s=NVRO

+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVRO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVRO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVRO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C

+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVRO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?

action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVRO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVRO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVRO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVRO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVRO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVRO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVRO+NVROh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVRO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVRO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVRO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVRO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVRO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVRO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVRO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVRO
Bussinessweek (businessweek.com):

http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVRO
StockTwits (stocktwits.com): http://stocktwits.com/symbol/NVRO

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO
👍️0
uptowndw uptowndw 10 años hace
WTF???? huge jump but on only 2k shares how is this possible?????
👍️0
Penny Roger$ Penny Roger$ 10 años hace
My back hurts. Congrats on IPO $NRVO!

https://www.google.com/finance?q=NVRO

Nevro Corp. is a medical device company focused on developing solutions in the neuromodulation space. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. The Company’s High-frequency spinal cord stimulation (SCS) system, the HF10 SCS, is a spinal cord simulation therapy, which provides electric pulses at a rate of approximately 10,000 Hz for spinal cord stimulation in the treatment of chronic back and leg pain. The electrical pulses are conveyed by small electrodes placed in the epidural space and connected to a battery-powered generator implanted under the skin. The Nevro Senza SCS system is available in Europe and Australia. It is undergoing a pivotal clinical trial, which is intended to collect data to support an application for a Nevro Senza implantable spinal cord stimulation system. The Company’s SENZA-RCT study is intended to evaluate the safety and effectiveness of the Senza SCS system.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock